Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 17 (EEF1A1P17) is a processed pseudogene of the EEF1A1 gene, located on chromosome 12q12 and spanning 1,413 nucleotides[2][4][5]. Pseudogenes are DNA sequences that resemble functional genes but typically lack protein-coding potential due to mutations or truncations incurred during evolution. EEF1A1P17 has no known protein product, no functional biological activity, and is not a validated therapeutic target. There is no robust evidence linking this pseudogene to disease, drug action, or physiological function. Most references to EEF1A1P17 in gene and protein databases simply confirm its status as a non-coding pseudogene, with no described molecular or pathological role[1][2][4]. The correct canonical therapeutic target in this family is the protein-coding parent gene, Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), which functions in translation elongation, but not EEF1A1P17[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 17 (EEF1A1P17).